Moreover, we previously found heterogeneous MGMT methylation in the only glioblastoma IDH-mutant, WHO (2016) grade IV patient in a cohort of 12 glioblastomas, WHO (2016) grade IV22. The gene discussed is IDH1; the disease is glioblastoma.